Filed: 11/14/2023ACC: 0000905148-23-001445
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $352.65M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$352.65M
Total AUM (reported)
30.44M
Total Shares
Allocation by class
COM$352.65M100.0%
Portfolio Concentration
Top 3$250.07M70.9%
4–10$102.58M29.1%
Top 3 weight
70.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 30.44M
Sole
Full voting authority
30.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
RAYZEBIO INC
SOLEShares5.16M
TypeSH
Market value$114.51M
32.47%
Sole
5.16M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares4.26M
TypeSH
Market value$89.00M
25.24%
Sole
4.26M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$46.56M
13.20%
Sole
9.70M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.85M
TypeSH
Market value$39.18M
11.11%
Sole
3.85M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.04M
TypeSH
Market value$33.93M
9.62%
Sole
1.04M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares758.80K
TypeSH
Market value$26.35M
7.47%
Sole
758.80K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.91M
TypeSH
Market value$1.93M
0.55%
Sole
2.91M
Shared
0.00
None
0.00
IMPEL PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$1.19M
0.34%
Sole
2.76M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RAYZEBIO INCSOLE | COM | 5.16M | SH | $114.51M 32.47% | 5.16M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 4.26M | SH | $89.00M 25.24% | 4.26M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $46.56M 13.20% | 9.70M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.85M | SH | $39.18M 11.11% | 3.85M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.04M | SH | $33.93M 9.62% | 1.04M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 758.80K | SH | $26.35M 7.47% | 758.80K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.91M | SH | $1.93M 0.55% | 2.91M | 0.00 | 0.00 |
IMPEL PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $1.19M 0.34% | 2.76M | 0.00 | 0.00 |